CALCIUM, AN IMPORTANT INTRA-and extracellular cation, plays an essential role in diverse functions ranging from forming structural elements in bone matrix to intracellular signaling. Calcium homeostasis is maintained by changes in the function of the small intestine, where absorption of calcium is modulated; the skeleton, where both reabsorption and deposition into bone are regulated; and the kidney, where renal tubular reabsorption of filtered calcium is controlled on the basis of the body's overall need for calcium retention or loss (14) . Because the kidney is the only one of these organs primarily involved in excretion, it has a dominant role in regulation of calcium metabolism (16) . The renal tubule has the ability to vary its reabsorption of filtered calcium to adjust for changes in intake or increased calcium requirements. Under normal conditions, Ͻ1% of filtered calcium is excreted in the urine (16) .
Calcium is reabsorbed throughout the nephron (26); however, most of the regulation of reabsorption occurs in the distal nephron. In the thick ascending limb of the loop of Henle (TAL), calcium reabsorption occurs through a primarily paracellular pathway, but active, transcellular reabsorption may occur as well during stimulation with parathyroid hormone (PTH) (16) . In the distal convoluted tubule (DCT), calcium reabsorption occurs through an active transcellular process against an electrochemical gradient. Calcium enters DCT cells at the apical surface through a calcium channel, traverses the intracellular space, and exits the cell at the basolateral surface either through a sodium-calcium exchange mechanism or by a plasma membrane calcium ATPase (PMCA). About 10% of the filtered calcium is reabsorbed in the DCT. The amount of calcium reabsorbed in the DCT, however, represents a key portion for regulation of reabsorption (36) . Because only a small percentage of filtered calcium is excreted in the urine, and the DCT is the last major sight for reabsorption of calcium, relatively small changes in the fraction reabsorbed in the DCT result in large changes in the total amount of calcium lost in the urine. Reabsorption in the DCT is regulated by PTH (14, 38) . When serum calcium concentration decreases, PTH release from the parathyroid glands increases. This effect is mediated by the calcium-sensing receptor (CaR) in the parathyroid gland. A direct mechanism by which calcium could inhibit its own transcellular reabsorption in the distal tubule (either TAL or DCT) has not been described previously. Several lines of evidence support the hypothesis that the CaR is present on the basolateral surface of DCT where it could inhibit calcium transport. CaR mRNA has been identified in distal tubule (33, 43) and cultured distal tubular cells (4) , and the receptor has been localized by immunocy-tochemistry to the basolateral surface of the distal tubule in rat kidney (32) . Activation of the CaR at the basal surface of dissected rat distal tubules causes release of calcium from intracellular stores (30) .
The Madin-Darby canine kidney (MDCK) cell line was originally derived from dog kidney and retains a number of characteristics of distal tubule, including the ability to form high-resistance monolayers that polarize, express antigens of the distal tubule, and transport calcium and other ions (20, 21, 28, 35) . MDCK cells have also been shown to be capable of transepithelial calcium transport that is stimulated by PTH (23) . Thus MDCK cells are a good model for the transcellular calcium absorption that occurs in DCT. We have grown MDCK cells on permeable supports and measured ion transport across cell monolayers. This laboratory has demonstrated previously that MDCK cells possess both mRNA (2) and protein (3) for CaR and that the CaR couples to G i␣ and G q␣ heterotrimeric G proteins (2) . We hypothesized that the CaR in the MDCK cell model of distal tubule inhibits transcellular calcium transport. In the present study, we demonstrate that the CaR inhibits calcium transport across an MDCK cell monolayer through a pathway that requires phospholipase C (PLC) but not G i␣ . Inhibition of calcium transport is potentially mediated through a basal calcium pump because the CaR inhibits PMCA activity through a pathway that is also PLC dependent. Unidirectional calcium transport assays. MDCK cells were grown in MEM media containing 10% fetal bovine serum (FBS) without antibiotics. Cells were dispersed with trypsin-EDTA and plated at 200,000 cells/well onto Falcon 3091 tissue culture inserts containing 3.0-m pores. The inserts were placed in six-well tissue culture plates under sterile conditions and grown to confluence (ϳ7 days). Confluence and generation of tight junctions were confirmed by measurement of resistance across the membrane. We have previously shown that calcium movement is more than six-fold higher in the apical to basal direction than for basal to apical movement by using this model (1 where JCa is the unidirectional calcium transport, cpm is the total number of counts in the lower chamber, * [Ca 2ϩ ] is the specific activity of calcium (cpm/M), A is the monolayer surface area (4.2 cm 2 ), and 10 6 converts micromoles to picomoles. In some studies, unidirectional calcium flux was divided by the number of minutes and expressed as picomoles per square centimeter per minute.
METHODS

Materials
Electrical measurements. Transepithelial voltage and resistance were measured by using a Millicell-ERS electrical resistance system (Millipore, Bedford, MA). Voltage (mV, apical surface relative to basal surface) and resistance were measured in five sets of inserts. Resistance was corrected for the contribution of the fluid and the insert itself and expressed as Ohms times square centimeters. MDCK cell monolayers were compared after 20 min of 0.1 or 5 mM calcium transport buffer on the basal surface. Both sets had transport buffer containing 0.1 mM calcium at the apical surface.
Pertussis toxin studies. To determine whether the effect of activation of the CaR was mediated through a pertussis toxin-sensitive G protein, monolayers of MDCK cells were treated with 200 ng/ml pertussis toxin for 16 h before transport assays. Calcium transport was measured as described above. Pertussis toxin from two different sources was used. To confirm that pertussis toxin completely ADP-ribosylated pertussis toxin-sensitive G proteins, in vitro ribosylation of membranes from cells that were treated with pertussis toxin, as described above, was compared with ribosylation seen in membranes from cells that were not pretreated with pertussis toxin. After treatment of monolayers with pertussis toxin, the media was aspirated and the cells were washed twice with cold PBS, then 400 l of lysis buffer (5 mM Tris-2 mM EGTA-10 l/ml Sigma protease inhibitor cocktail) were added and the cells were immediately scraped into a Dounce homogenizer. The insert was washed with an additional 400 l lysis buffer that were transferred to the Dounce and homogenized. Homogenate was centrifuged for 30 min at 13,000 rpm. The pellet was resuspended in 150 l of 50 mM Tris (pH 7.4), washed twice with the same buffer, and resuspended in a volume of 100 l of ribosylation buffer [(in mM) 25 Tris (pH 8.0), 100 NaCl, 1 dithiothreitol (DTT), 2.5 MgCl, 0.5 EDTA, and 10 thymidine, as well as 10 M NAD, 100 M ATP, 10 M GTP, 5 g preactivated pertussis toxin (per condition)] (24) and 5 Ci [ 32 P]NAD at 37°C. At the end of 1 h, the sample was centrifuged at 14,000 g for 15 min, separated on a 12% SDS-PAGE gel, and bands were visualized by autoradiography.
PMCA activity. MDCK cells were grown on permeable tissue culture inserts as described above. On day 5, the basolateral medium was changed to Ham's F-12 nutrient mixture with 10% FBS. On day 6, cells were treated for 20 min with buffer containing 130 mM NaCl, 16.5 M HEPES, 5.4 M KCl, 0.1 mM K 3PO4, and the appropriate concentration of CaCl2. Immediately following treatments, inserts were transferred to six-well trays on ice containing chilled phosphate-buffered saline. Subsequent steps were performed on ice. Cells were harvested with cell scrapers into chilled lysis buffer containing 5 mM Tris, 2 mM EGTA, 20 M DTT, and Sigma protease inhibitor cocktail (100 l/10 7 cells). Cells were homogenized in a Dounce homogenizer and sonicated at the minimum setting with three short bursts (Braun-Sonic 2000). Cell debris was removed by centrifugation at 700 g for 3 min. Membranes were pelleted by centrifugation at 15,000 g for 30 min and resuspended in 50 mM Tris ⅐ HCl (pH 7.4), 0.3 M sucrose, 0.1 M KCl, 2 mM DTT, and Sigma protease inhibitor cocktail (100 l/10 7 cells). PMCA activity of 10-20 g of membranes was assayed by using a coupled enzyme system in which ATP hydrolysis is coupled to NADH oxidation with pyruvate kinase (PK), lactate dehydrogenase (LDH), and phosphoenolpyruvate (PEP), as previously described (12). The assay was performed in a 200-l volume in a Costar UV-compatible 96-well plate at 37°C with a Bio-Tek Powerwave X plate reader. The assay substrate included 0.01 M TES, 0.1 M KCl, 420 M PEP, 5 mM ATP, 5 mM MgCl 2, 400 M NADH, 7.5 U/ml PK, 18 U/ml LDH, 2 mM DTT, 50 nM calmodulin, 200 nM thapsigargin, and either 10 M CaCl2 or 5 mM EGTA. Absorbance at 340 nm was monitored continuously for 3 min before and 13 min after addition of membranes. The difference in the rate of ATP hydrolysis in the presence of calcium and EGTA was used to calculate the calcium-ATPase activity. The use of thapsigargin eliminated contributions from internal membrane calcium ATPases.
Data analysis. Data were analyzed by using one-way repeated measures ANOVA followed by Tukey's test or by a paired t-test with Bonferroni correction for multiple comparisons.
RESULTS
MDCK cells were grown to confluence on the tissue culture inserts and developed electrically tight junctions. Calcium-45 transport was measured across the monolayer and occurred in a time-dependent manner. To determine whether stimulation of the CaR could inhibit calcium transport across the monolayer, 5 mM CaCl 2 was added to the basal surface of the monolayer and calcium transport was measured over a 20-min period (Fig. 1A) . Stimulation of the CaR resulted in an inhibition of unidirectional calcium transport that was statistically significant after 10 min. To determine whether the inhibition of calcium transport by the CaR occurred within a physiologically relevant range, a concentration-response curve with increasing concentrations of CaCl 2 was done (Fig. 1B) . Stimulation of the CaR on the basal surface of the MDCK cell monolayer inhibited calcium transport over a range from 0.1 to 1.7 mM without a further decrease in transport at concentrations as high as 10 mM CaCl 2 . To confirm that changes in calcium concentration could inhibit calcium transport in the physiological range, we stimulated the basal surface of the monolayer with either 0.7 or 1.3 mM CaCl 2 for 20 min. Stimulation with 1.3 mM calcium resulted in a 6% inhibition of calcium transport relative to 0.7 mM (P Ͻ 0.01, n ϭ 7). This indicates that the MDCK cell CaR inhibits calcium transport over a physiologically relevant range.
To confirm that calcium caused changes in transcellular calcium movement and did not produce changes in the physical characteristics of the membrane that would alter paracellular transport, we measured resistance and electrical potential across the MDCK cell monolayer. Changing basal calcium concentration from 0.1 to 5 mM did not alter transmonolayer resistance (1,189 Ϯ 197 vs. 1,581 Ϯ 210 ⍀/cm 2 , n ϭ 5) or transmonolayer potential (Ϫ1.9 Ϯ 0.3 vs. Ϫ1.6 Ϯ 0.2 mV, n ϭ 5). These data demonstrate that changes in transepithelial calcium transport were due to alterations in transcellular transport and not to paracellular movement of calcium, and confirm the previous findings that MDCK cells are capable of transcellular calcium transport.
To confirm that the inhibition of calcium transport produced by basal administration of CaCl 2 was mediated through the CaR and not simply by a change in the concentration gradient for calcium across the cell http://ajprenal.physiology.org/ monolayer, we used two additional CaR agonists. Concentration-response curves were done with gadolinium and neomycin to determine their effects on calcium transport after addition to the basal surface. Both gadolinium ( Fig. 2A) and neomycin (Fig. 2B) inhibited calcium transport in a concentration-dependent manner. Inhibition by both agents occurred in the range that had been described previously for activation of the CaR.
We had previously demonstrated that the CaR stimulates both G i␣ and G q␣ proteins in MDCK cells. To determine whether G i␣ proteins mediated the inhibition of calcium transport by the CaR, MDCK cell monolayers were pretreated with pertussis toxin (200 ng/ml, 16 h). Concentrations of CaR agonists that gave a maximal response were used. Stimulation with the CaR agonists calcium, gadolinium, and neomycin caused similar decreases in calcium transport. Pretreatment with pertussis toxin did not prevent the inhibition of calcium transport produced by basal administration of the CaR agonists (Fig. 3, A-C) . To confirm that the treatment had ADP-ribosylated G proteins, the ability of pertussis toxin to ADP-ribosylate G proteins in membranes after overnight pertussis toxin treatment of intact cells was evaluated. Membranes obtained from cells that were not pretreated with pertussis toxin were able to be ADP-ribosylated by a 1-h treatment with activated pertussis toxin in the presence of [ (Fig. 3D ). These studies demonstrate that pertussis toxin treatment of intact cells on tissue culture inserts fully ADP-ribosylates the pertussis toxin-sensitive G proteins and that G i␣ proteins are not involved in the inhibition of calcium transport by the CaR.
To determine whether PLC was involved in the inhibition of calcium transport by the CaR, the inhibitor U-73122 and its inactive analog U-73343 were used (Fig. 4) . U-73343 did not effect the ability of the CaR to inhibit J Ca . U-73122 pretreatment increased basal calcium transport across the cell monolayer compared with U-73343 and blocked the ability of the CaR to inhibit calcium transport. Thus whereas pertussis toxin-sensitive G proteins are not necessary for the inhibition of calcium transport, PLC is required. In addition, PLC may exert a tonic inhibition of calcium transport that is released by treatment with U-73122.
We next investigated a potential mechanism by which the CaR could inhibit calcium transport, alteration of PMCA activity. PMCA activity was measured in MDCK cells in response to stimulation of the CaR to determine whether inhibition of PMCA was responsible for the decreased calcium transport produced by the CaR. The basal surface CaR of the intact MDCK cell monolayer was stimulated, as described, for measurement of calcium transport. PMCA activity was compared in purified membranes from cells exposed to low (0.1 mM) or high (5 mM) calcium at the basal surface for 20 min before membrane preparation. Basal PMCA activity in membranes from cells exposed to low calcium was 27 Ϯ 3 nmol⅐ min Ϫ1 ⅐ mg
Ϫ1
. Stimulation of the basal surface CaR with high calcium caused nearly complete inhibition of PMCA activity (Fig. 5A) . To determine whether CaR activation inhibited PMCA activity in the relevant physiological range, a concentration-response curve was done for PMCA activity after stimulation of the basal surface of intact cell monolayers. Stimulation of the basal surface CaR inhibited PMCA activity in a concentration-dependent manner (Fig. 5B) . Inhibition of PMCA activity was nearly complete at a concentration of 1.4 mM calcium. In a separate set of experiments, the effect of two calcium concentrations on PMCA activity was compared. High calcium (1.3 mM) resulted in a 72% reduction in PMCA activity compared with low calcium (0.7 mM, P Ͻ 0.05, data not shown).
Finally, to determine whether inhibition of PMCA by the CaR requires PLC, MDCK cell monolayers were pretreated with the PLC inhibitor U-73122 or its inactive analog U-73343 (5 M, 1 h). After a 20-min treatment with or without calcium, cell membranes were prepared and PMCA activity was determined and expressed as percent change relative to the control (U-73343) without calcium (Fig. 6) . Pretreatment with U-73122 increased PMCA activity relative to treatment with U-73343 (P Ͻ 0.05). Membranes from cells pretreated with the control substance showed the typical nearly complete inhibition of PMCA activity after stimulation of the CaR for 20 min. In contrast, in cells pretreated with U-73122, stimulation of the CaR did not cause a statistically significant inhibition of PMCA Fig. 2 . Concentration-response relationship for inhibition of unidirectional calcium transport (JCa) by the calcium-sensing receptor (CaR) agonist. CaR agonists were added to the basal surface of MDCK cells to determine their effect on calcium transport. A: gadolinium inhibits calcium transport in a concentration-dependent manner (n ϭ 6). B: neomycin inhibits calcium transport in a concentration-dependent manner (n ϭ 6). *P Ͻ 0.05. activity. To determine the effect within each treatment group, the effect of calcium on PMCA activity was compared in U-73343-or U-73122-treated cells. CaR stimulation caused an 84 Ϯ 12% inhibition of PMCA in cells pretreated with U-73343. In cells where PLC was inhibited, CaR stimulation resulted in a 35 Ϯ 34% inhibition relative to U-73122 pretreatment alone. The response to CaR stimulation between the two groups was statistically significant (n ϭ 6, P Ͻ 0.05, data not shown). These results are consistent with the effect of inhibition of PLC on calcium transport. The increase in calcium transport seen after treatment with U-73122 may be mediated by an increase in activity of the Membranes were prepared and PMCA activity was measured (n ϭ 10). Stimulation with calcium (filled bar) resulted in a decrease in PMCA activity compared with control (hatched bar). B: the basal surface of MDCK cell monolayers was stimulated with increasing concentrations of calcium, and PMCA activity was measured in purified membranes (n ϭ 5). Calcium inhibited PMCA activity in a concentration-dependent manner. *P Ͻ 0.05.
PMCA. Similarly, inhibition of PLC blocks the ability of the CaR to inhibit both calcium transport and PMCA activity.
DISCUSSION
The studies described herein provide evidence that the CaR inhibits calcium absorption in a model of the renal distal tubule. Although inhibition of paracellular calcium reabsorption by the CaR in the TAL has previously been postulated, this is the first evidence for regulation of calcium transport by calcium via a transcellular pathway in the distal tubule. Inhibition of the response by U-73122, but not pertussis toxin, suggests that G q␣ , but not G i␣ , is involved. Furthermore, these studies demonstrate that inhibition of calcium transport by the CaR is caused, at least in part, by inhibition of PMCA activity.
One possible mechanism by which addition of calcium to the basal surface of the monolayer could inhibit calcium transport is through a direct, nonreceptormediated effect based on the increased gradient against which the calcium is transported or an increase in calcium entry due to increased extracellular calcium concentration. The present study provides evidence that inhibition of calcium transport by calcium is mediated by the CaR. First, inhibition occurs across a range of calcium concentrations that includes physiological concentrations with little additional inhibition seen at higher calcium levels, as seen in Fig. 1 . Second, the CaR agonists neomycin and gadolinium also inhibit calcium transport. The concentrations of gadolinium and neomycin used are consistent with its demonstrated potency at the cloned CaR (9, 17, 34) . Third, the inhibition of the effect of the CaR by the PLC inhibitor U-73122 is most consistent with a receptor-mediated effect. Fourth, the effect was not due to a change in membrane resistance or electrical potential caused by higher concentrations of calcium, because these were measured and did not change. Finally, inhibition of PMCA activity by addition of calcium to the basal surface of the cell is most likely caused by a receptor, as the stimulation of the receptor occurred in the intact cell, whereas the activity was measured in isolated membranes that have been washed a number of times. In addition, the inhibition of PMCA by CaR is evidence that the effect on calcium transport is not mediated by a change in membrane potential but rather by a direct effect on the calcium pump.
The decrease in calcium appearing at the basal surface could also not be mediated by increased backflux of calcium-45. Initial concentration of "hot" calcium-45 in the apical compartment are 2.5 in 100 M total ("hot" plus "cold") calcium. Thus, of the ϳ1,200 pmol/cm 2 of calcium transport seen in Fig. 1 2 ), this is 126 pmol of hot calcium-45 moving into the lower buffer containing 5 M/ml cold calcium. Therefore, the specific activity of the apical solution is Ͼ100,000 times greater than that of the basal solution, even assuming that all of the apical-to-basal transport occurs immediately, which it does not. Because of the difference in specific activity, for increased backflux of calcium to account for the differences seen, the backflux would have to be 100,000-fold greater than apical-to-basal transport. We have shown that the backflux is more than sixfold less under resting conditions (1) .
Hebert and colleagues (10) have proposed that activation of the basolateral CaR in the TAL inhibits calcium reabsorption from the TAL. This reabsorption occurs largely through a passive paracellular pathway driven by generation of a lumen positive gradient. Stimulation of the CaR in TAL inhibits apical potassium channels via a cytochrome P-450-(42) and phospholipase A 2 -dependent (41) pathway. Administration of calcium to the basal surface of intact TAL has also been shown to inhibit cAMP formation (39) and decrease chloride absorption in a phospholipase A 2 -independent manner (11) . Inhibition of both the apical K channel and chloride reabsorption would be expected to decrease the lumen positive gradient and thus decrease calcium reabsorption. These data suggest, but do not prove, that calcium can regulate its own reabsorption in the TAL. In the absence of regulation of PMCA activity was measured in cell membranes. U-73122 increased PMCA activity and inhibited the ability of the CaR to decrease PMCA activity (n ϭ 6). *P Ͻ 0.05 compared with U-73343, no calcium.
calcium reabsorption in the distal tubule, however, the effect of decreased TAL absorption would be diminished by increased reabsorption in the distal tubule, where up to 90% of delivered calcium can be absorbed (38) .
In the distal tubule, calcium reabsorption occurs through an active transcellular transport process (16) . Calcium enters at the apical surface through a calcium channel and exits the cell at the basal surface via a sodium-calcium exchanger (NCE) or PMCA (14) . In the dog, unlike most other species, NCE is primarily localized in the connecting tubule and not in DCT (8) . In MDCK cells, NCE functional activity (27) and Northern blot for NCE (31) are both absent. Therefore, the most likely mechanism for extrusion from the cell at the basal surface is by PMCA. Previous studies have localized both PMCA (5) and the CaR (32) at the basal surface of the distal tubule. In addition, we have demonstrated both functional and immunological evidence for polarized localization of CaR to the basal surface of MDCK cells (3) . Because both PMCA and CaR are located at the basal surface, inhibition of PMCA by the CaR is a potential mechanism by which calcium could inhibit net calcium transport across the tubule. PMCA is positively and negatively regulated by a number of intracellular substances including calmodulin, proteases, protein kinases, and acidic phospholipids (29) . In the distal tubule, PMCA activity is stimulated by PTH (40) , which provides an indirect feedback loop to regulate calcium absorption. The present study demonstrates that one mechanism by which the CaR inhibits calcium absorption is by inhibiting PMCA activity. The effect of the CaR on both calcium transport and PMCA activity was inhibited by U-73122. Because the CaR activates G q␣ , a likely sequence of intracellular events is CaR activation followed by activation of G q␣ and PLC. This could lead to a change in the phosphorylation state of PMCA or a change in other regulators of PMCA activity. These data do not rule out the possibility that calcium uptake into the cell or NCE activity in intact tubules could also be regulated by the CaR. Until recently, the pathway for calcium entry into renal epithelia cells was unclear. Bindels and colleagues (22) have identified a novel calcium channel cloned from renal cells that may be responsible for calcium entry; however, its regulation has not been described.
The DCT is the primary segment for regulation of calcium absorption by PTH, calcitonin, and vitamin D 3 (16) . PTH increases absorption of calcium in the distal tubule (6, 25, 26, 37) and in cell culture models of distal tubule (13, 18, 23) . Calcitonin increases calcium transport in distal tubule cells (19) . Vitamin D increases calcium absorption in distal tubular membranes (7) and cells (15) . In contrast, stimuli that decrease calcium reabsorption in the distal tubule have not been identified. Therefore, the role of serum calcium as a negative regulator of calcium reabsorption is important in overall calcium homeostasis. As serum calcium increases, the CaR on the basal surface of distal tubular cells is activated and results in decreased reabsorption of calcium and thus increased urinary losses. Acting in concert with this effect is the suppression of PTH release by increased serum calcium concentration and removal of the stimulus for reabsorption.
These studies have demonstrated for the first time that calcium can inhibit its own transcellular absorption in a model of distal tubule. This represents an important physiological mechanism for calcium homeostasis. In addition, we have shown that the regulation of calcium absorption is mediated through inhibition of the PMCA. The mechanism by which the CaR inhibits PMCA remains to be determined, but the MDCK cell model will prove useful in determining the signal transduction pathways involved.
